Literature DB >> 18258935

Strategies for prescribing statins.

Norbert Donner-Banzhoff, Andreas Sönnichsen.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18258935      PMCID： PMC2234555          DOI： 10.1136/bmj.39387.573947.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

Review 3.  Resource management in prevention of coronary heart disease: optimising prescription of lipid-lowering drugs.

Authors:  James Shepherd
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

4.  Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk.

Authors:  Rod Jackson; Carlene M M Lawes; Derrick A Bennett; Richard J Milne; Anthony Rodgers
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

Review 5.  Should we lower cholesterol as much as possible?

Authors:  Uffe Ravnskov; Paul J Rosch; Morley C Sutter; Mark C Houston
Journal:  BMJ       Date:  2006-06-03

6.  Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Authors:  P Jones; S Kafonek; I Laurora; D Hunninghake
Journal:  Am J Cardiol       Date:  1998-03-01       Impact factor: 2.778

7.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.

Authors:  T A Pearson; I Laurora; H Chu; S Kafonek
Journal:  Arch Intern Med       Date:  2000-02-28

8.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

9.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

10.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.

Authors:  P M Kearney; L Blackwell; R Collins; A Keech; J Simes; R Peto; J Armitage; C Baigent
Journal:  Lancet       Date:  2008-01-12       Impact factor: 79.321
View more
  4 in total

1.  Strategies for statins: The CASE for fire and forget.

Authors:  L Sam Lewis
Journal:  BMJ       Date:  2008-02-23

2.  Strategies for statins: Treat to target benefits no one.

Authors:  D Graham Mackenzie; Philip Rutledge
Journal:  BMJ       Date:  2008-02-23

3.  Barriers and Facilitators to Using Statins: A Qualitative Study With Patients and Family Physicians.

Authors:  Sonia Butalia; Rachelle C W Lee-Krueger; Kerry A McBrien; Alexander A C Leung; Todd J Anderson; Hude Quan; Christopher Naugler; Guanmin Chen; David J T Campbell
Journal:  CJC Open       Date:  2020-07-04

4.  A cluster randomised controlled trial of a pharmacist-led collaborative intervention to improve statin prescribing and attainment of cholesterol targets in primary care.

Authors:  Richard Lowrie; Suzanne M Lloyd; Alex McConnachie; Jill Morrison
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.